대두 이소플라본 보충과 운동이 폐경 후 여성의 소변 칼슘, 마그네슘, 구리, 아연 배설량에 미치는 영향 = Effects of Soy Isoflavones Supplementation and Exercise on Urinary Calcium, Magnecium, Copper and Zinc Excretion in Postmenopausal Women

국문 초록 (Abstract)

골다공증의 위험율이 높은 폐경 후 여성을 대상으로 이소플라본 보충과 운동의 단독 또는 복합적인 중재가 소변칼슘, 마그네슘, 구리, 아연배설량에 미치는 영향을 알아보기 위하여 45∼67세의 폐경 후 여성 67명을 연령, 체질량지수와 Base line 골밀도에 차이가 없도록 대조군 (16명), 보충군 (19명), 운동군 (16명), 보충 + 운동군 (16명)으로 나누어 연구를 수행하였다. 보충 + 운동군과 보충군에게는 8주 동안 매일 이소플라본 90 mg을 보충하였으며 운동군과 보충+운동군에게는 함께 운동을 실시한 후 중재전후의 소변 칼슘, 마그네슘, 구리, 아연 배설량 변화를 측정하여 다음과 같은 결과를 얻었다.
소변의 칼슘, 마그네슘, 구리의 배설량은 유의적인 변화를 보이지 않았다. 그러나 식이 아연의 섭취량이 운동과 이소플라본 보충을 실시하는 동안 변화가 없었음에도 불구하고, 이소플라본 보충군에서 소변 아연의 배설량이 유의적으로 감소하여 이소플라본의 보충이 골대사에 중요한 역할을 하는 아연 보유량을 증가시킨 것으로 나타났다.
이상의 결과를 통하여 폐경 후 여성에서 운동과 이소플라본의 동시 중재가 각각의 중재방법보다 골대사의 향상에 유의적인 상승 작용이 없음을 확인 할 수 있었다. 또한 이소플라본의 단독 보충군에서만 소변의 아연 배설량을 감소시키는 다소 미미한 연구 결과가 제시되었다. 그러나 본 연구는 연구 기간이 짧고, 이소플라본의 보충량이나 운동의 중재방법이 다양하지 못하다는 많은 제한점을 가지고 있으므로, 추후 효과적인 투여 농도와 운동중재 방법을 모색하고, 또한 운동과 기능성 식이성분의 효과적인 복합 중재방법을 결정 할 수 있는 계속적인 연구가 필요하다고 본다.

다국어 초록 (Multilingual Abstract)

This study assessed the effects of soy isoflavones supplementation with exercise on urinary mineral (calcium, magnesium, copper, zinc) excretion as an index of bone resorption rates in 67 postmenopausal women. A total subjects were assigned to Isoflavone (90 ㎎/day) or placebo groups. These groups were further divided into groups that undergone a regular exercise or a rather sedentary state performing daily activity only. We conducted study eight week period. Result showed urinary zinc excretion was more significantly decreased in the isoflavone-sedentary group (-180.76 ± 171.30 ㎍/day) than in the placebo-sedentary group (-31.23 ± 146.60 ㎍/day), placebo-exercise group (40.93 ± 193.44 ㎍/day) and isoflavione-exercise group (-1.21 ± 160.61 ㎍/day) (p ＜ 0.05), but no significant changes in the differences between the values of the pre and post study values in urinary calcium, magnesium and copper excretion. These results suggest that Isoflavone supplementation decrease urinary zinc excretion rate in postmenopausal subjects.

목차 (Table of Contents)

• ABSTRACT
• 서론
• 연구방법
• 결과
• 고찰
• 요약
• Literature cited

참고문헌 (Reference)

• 1 승정자, "폐경 후 여성에서 대두 이소플라본 공급 및 운동처방이 골밀도 및 소변 디옥시피리디놀린에 미치는 영향" 한국영양학회 37 (37): 291-301, 2004
• 2 나혜복, "칼슘보충 섭취와 운동이 중년 여성의 골밀도에 미치는 영향" 한국영양학회 35 (35): 962-969, 2002
• 3 김미현, "일부 폐경 후 여성의 영양소 섭취수준에 따른 골밀도와소변 중 골대사 지표 비교연구" 한국영양학회 40 (40): 719-727, 2007
• 4 최미자, "이소플라본 섭취수준이 성장기 암컷 쥐의 골대사지표 및골대사관련호르몬에 미치는 영향" 한국영양학회 41 (41): 199-205, 2008
• 5 최윤희, "생리적 요인과 생활습관이 폐경 후 여성의 골밀도에 미치는 영향" 한국영양학회 40 (40): 517-525, 2007
• 6 Relea P, "Zinc, biochemical markers of nutrition, and type I osteoporosis" 24 (24): 303-307, 1995
• 7 Szathmari M, "Zinc excretion in osteoporotic women" 134 (134): 911-914, 1993
• 8 Ohry A, "Zinc and osteoporosis in patients with spinal cord inhury" 18 (18): 174-180, 1980
• 9 Schlemmer A, "Urinary magnesium in early postmenopausal women. influence of hormone therapy on calcium" 10 (10): 34-39, 1991
• 10 Schlemmer A, "Urinary magnesium in early postmenopausal women. influence of hormone therapy on calcium" 10 (10): 34-39, 1991
• 11 Gambacciani M, "Ultra low-dose hormone replacement therapy and bone protection in postmenopausal women" 59 (59): 2-6, 2008
• 12 Bureau I, "Trace mineral status in post menopausal women: impact of hormonal replacement therapy" 16 (16): 9-13, 2002
• 13 Lieberman S, "The real vitamin & mineral book. Avery publishing group" Garden city park 1997
• 14 Brodowska A, "The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes" 49 : 111-133, 2003
• 15 Rico H, "The effect of supplemental copper on osteopenia induced by ovariectomy in rats" 7 (7): 413-416, 2000
• 16 Herzberg M, "The effect of estrogen replacement on zinc in serum and urine" 87 (87): 1035-1040, 1996
• 17 Danz AM, "The effect of a specific strength-development exercise on bone mineral density in perimenopausal and postmenopausal women" 7 (7): 701-709, 1998
• 18 Park HM, "The distribution and transition of postmenopausal population in Korea" 4 (4): 61-71, 1998
• 19 Burrows M, "The components of the female athlete tried donot identify all physically active female at risk" 25 (25): 1289-1297, 2007
• 20 Nordin BEC, "The calcium deficiency model for osteoporosis" 47 : 65-72, 1989
• 21 Spelsberg TC, "The actions and interactions of sex steroids and growth factors/cytokines on the skeleton" 13 (13): 819-828, 1999
• 22 Sievanen H, "The Achilles heel of exercise" 355 (355): 469-470, 2000
• 23 Nechushton H, "Tamoxifen and Breast Cancer" 141 (141): 718-720, 2002
• 24 Estok PJ, "Structural model for osteoporosis preventing behavior in postmenopausal women" 56 (56): 148-158, 2007
• 25 Arjmandi BH, "Soy protein has a greater effect on bone in postmenopausal women not on hormone replacement therapy, as evidenced by reducing bone resorption and urinary calcium excretion" 88 (88): 1048-1054, 2003
• 26 Ye YB, "Soy isoflavones attenuate bone loss in early postmenopausal Chinese women: a singleblind randomized placebo-controlled trial" 45 (45): 327-334, 2006
• 27 Somekawa Y, "Soy intake related to menopausal symptoms, serum lipids, and bone mineral density in postmenopausal Japanese women" 97 (97): 109-115, 2001
• 28 Namiduru ES, "Serum prolidase activity in postmenopausal osteoporosis" 98 (98): 647-651, 2007
• 29 North American Menopause Society, "Role of progestogen in hormone therapy for postmenopausal women: position statement of The North American Menopause Society" 10 (10): 113-132, 2003
• 30 Dawson-Hughes B, "Rate of bone loss in postmenopausal women randomized to two dosages of vitamine D" 61 : 1140-1145, 1995
• 31 Munger RG, "Prospective study of dietary protein intake and risk of hip fracture in postmenopausal women" 69 (69): 147-152, 1999
• 32 Prince LR, "Prevention of postmenopausal osteoporosis. A comparative study of exercise, calcium supplementation, and hormone- replacement therapy" 325 : 1189-, 1991
• 33 Arana-Arri E, "Prevalence of certain osteoporosis-determing habitsamong postmenopausal women in the Basque Country Spain in 2003" 81 (81): 647-656, 2007
• 34 Kamel HK, "Postmenopausal osteoporosis: etiology, current diagnostic strategies and nonprescription interventions" 12 (12): 4-9, 2006
• 35 Wu J, "Possible role of equol status in the effects of isoflavone on bone and fat mass in postmenopausal Japanese women: a double-blind, randomized, controled trial" 4 (4): 866-874, 2007
• 36 Loh KY, "Osteoporosis: primary prevention in the community" 62 (62): 355-357, 2007
• 37 Gartner R, "Osteoporosis in the elderly-diagnosis and treatment" 147 (147): 35-36, 2005
• 38 Schwab P, "Nonpharmacological approaches to improve bone health and reduce osteoporosis" 20 (20): 213-217, 2008
• 39 Rickard DJ, "Molecular and cellular mechanisms of estrogen action on the skeleton" 32 : 123-132, 1999
• 40 Cecchettin M, "Metabolic and bone effects after administration of ipriflavone and salmon calcitonin in postmenopausal osteoporosis" 49 : 465-468, 1995
• 41 Wong MY, "Medication-induced osteoporosis" 5 (5): 139-145, 2007
• 42 Karck U, "Low-dose oral contraception and bone density" 58 (58): 547-551, 2001
• 43 Kaplan B, "Low dose estrogen replacement therapy in early postmenopausal women effect on urinary magnesium and calcium: creatinine ratios" 21 (21): 170-172, 1994
• 44 Klavy LM, "Lack of a recommended dietary allowance for copper may be hazardous to your health" 17 (17): 322-326, 1998
• 45 Shiquemoto GE, "Isoflavones-supplemented soy yoghurt associated with resistive physical exercise increase bone mineral density of ovariectomized rats" 57 (57): 261-270, 2007
• 46 Alekel DL, "Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women" 72 (72): 844-852, 2000
• 47 Bush RA, "Female high-school varsity athletics: An opportunity to improve bone mineral density"
• 48 Eriksen EF, "Evidence of estrogen receptors in human osteoblast-like cells" 241 (241): 84-86, 1988
• 49 Park JH, "Estrogen deficiency and low-calcium diet increased bone loss and urinary calcium excretion but did not altor arterial stiffness in young female rats" 26 (26): 218-225, 2008
• 50 Hawse JR, "Estrogen Receptor{ beta} Isoform-specific Induction of Transforming Growth Factor{beta}-Inducible Early Gene-1 in Human osteoblast cells" 22 (22): 1579-1595, 2008
• 51 Potter SM, "Erdman JR JW. Soy protein and isoflavones: their effects on blood lipids and bone density in postmenoapusal women" 68 : 1375-1379, 1998
• 52 Kim NN, "Effects of tamoxifen on vaginal blood flow and epithelial morphology in the rat" 6 : 14-, 2006
• 53 Spence LA, "Effects of soy isoflavones on calcium kinetics in postmenopausal women" 16 : 532-, 2001
• 54 Going S, "Effects of exercise on bone mineral density in calcium-replete postmenopausal women with and without hormone replacement therapy" 14 (14): 637-643, 2003
• 55 Valente M, "Effects of 1-year treatment with ipriflavone on bone in postmenopausal women with low bone mass" 54 (54): 377-380, 1994
• 56 Valente M, "Effects of 1-year treatment with ipriflavone on bone in postmenopausal women with low bone mass" 54 (54): 377-380, 1994
• 57 Carvalho DC, "Effect of treadmill gait on bone markers and bone mineral density of quadriplegic subjects" 39 (39): 1357-1363, 2006
• 58 Sung CJ, "Effect of soymilk and bone mineral density and bone metabolism pelated markers in under-weight college women with low bone density" 5 (5): 132-140, 2003
• 59 Lee DH, "Effect of soy isoflavone supplementation on bone metabolism maker and urinary mineral excretion in postmenopausal women" 35 (35): 476-482, 2003
• 60 Mcnair P, "Effect of menopause and estrogen substitutional therapy on magnesiun metabolism" 10 (10): 84-87, 1984
• 61 Recker RR, "Effect of estrogens and calcoum carbonate on bone loss in postmenopausal women" 87 : 649-655, 1977
• 62 Vatanparast H, "Dose the effect of soy phytoestrogens on bone postmenopausal women depend on the equolproducing phenotype?" 65 (65): 294-299, 2007
• 63 Robinson JA, "Direct action of anturally occurring estrogen metabolites on human osteoblastic cells" 15 (15): 499-506, 2000
• 64 Ogita M, "Differentiation and proliferation of periosteal Osteoblast Progenitors are Differentially Regulated by Estrogens and Intermittent PTH Administration"
• 65 Itoh R, "Dietary protein intake and urinary excretion of calcium: a cross-sectional study in a healthy Japanese population" 67 (67): 438-444, 1998
• 66 Bianco V, "Diet assessment and the screening for osteoporosis: a survey in a healthy menopause population" 60 (60): 299-310, 2008
• 67 Lipscomb ER, "Comparative effects of animal and legume proteins on urinary calcium, urinary sulfate, and urynary net acid excretion and kidney function in postmenopausal women" 16 : 532-, 2001
• 68 Levesgue M, "Characterization of cadmium uptake and cytotoxicity in human osteoblast-like MG- 63 cells"
• 69 Garnero P, "Biomarkers for osteoporosis management: utility in diagnosis, fracture risk presiction and therapy monitoring" 12 (12): 157-170, 2008
• 70 Kotkowiak L, "Behavior of selected bio-elements in women with osteoporosis" 43 : 225-238, 1997
• 71 Gallagher JC, "Advances in bone biology and new treatments for bone loss" 60 (60): 65-69, 2008
• 72 Bailey DAm McKay HA, "A six-year longitudinal study of the relationship of physical activity to bone mineral accrual in growing children: The university of Saskatchewan bone mineral accrual study" 14 (14): 1672-1679, 1999
• 73 Ashizawa N, "A bout of resistance exercise increase urinary calcium independently of osteoclast activation in man" 83 (83): 1159-1163, 1997